- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Stem Cell Lawsuit Back Again
19 September 2011 4:35 pm
As expected, the plaintiffs in a law suit claiming that federally funded research on human embryonic stem cells (hESC) is illegal have appealed a ruling that dealt them a defeat earlier this summer.
Scientists James Sherley and Theresa Deisher filed their suit 2 years ago, arguing that the National Institutes of Health (NIH's) policy easing Bush-era restrictions on research using hESCs violated a law banning federally funded research that destroys embryos. U.S. District Judge Royce Lamberth agreed in August 2010 and granted a preliminary injunction in their favor that halted hESC research. But an appeals court soon stayed the injunction and last spring ruled 2-1 in favor of NIH. In July, Lamberth too ruled in favor of NIH, writing that he had little choice but to follow the appeals court decision.
The plaintiffs have now appealed Lamberth's ruling in a two-page notice dated 19 September. The appeals court will now issue a schedule for briefs and oral arguments. Legal experts have predicted that the plaintiffs will lose in the appeals court and will take their case to the U.S. Supreme Court, where their chances of success also seem slim.